FILTER
Prikaži samo sadržaje koji zadovoljavaju:
objavljeni u periodu:
na jeziku:
hrvatski engleski
sadrže pojam:

Task force to analyse applicability of Dinutuximab Beta in each case

Author: Marija Šestan

ZAGREB, June 19 (Hina) - An expert commission of the Croatian Health Insurance Fund (HZZO) stated on Monday afternoon that it would analyse each individual case and its admissibility for the application of Dinutuximab Beta, a drug for children with the rare high-risk neuroblastoma.

(Hina) ms

An unhandled error has occurred. Reload 🗙